# Capecitabine and Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer

> **NCT00104689** · PHASE2 · COMPLETED · sponsor: **UNICANCER** · enrollment: 60 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** capecitabine
- **DRUG:** oxaliplatin

## Key facts

- **NCT ID:** NCT00104689
- **Lead sponsor:** UNICANCER
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06-30
- **Primary completion:** 2007-03-31
- **Final completion:** 2008-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00104689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00104689, "Capecitabine and Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00104689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*